Your browser doesn't support javascript.
loading
Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia.
Megías-Vericat, Juan E; Montesinos, Pau; Herrero, María J; Moscardó, Federico; Bosó, Virginia; Martínez-Cuadrón, David; Poveda, José L; Sanz, Miguel Á; Aliño, Salvador F.
Affiliation
  • Megías-Vericat JE; aPharmacogenetics Unit, Institute for Health Research La Fe and Drug Clinical Area bDepartment of Pharmacy, Drug Clinical Area cDepartment of Hematology dClinical Pharmacology Unit, Hospital Universitari i Politecnic La Fe eDepartment of Pharmacology, Faculty of Medicine, Universidad de Valencia, Valencia, Spain.
Pharmacogenet Genomics ; 27(7): 270-274, 2017 07.
Article in En | MEDLINE | ID: mdl-28570300
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Polymorphism, Single Nucleotide / Cytarabine / Induction Chemotherapy Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Journal: Pharmacogenet Genomics Journal subject: FARMACOLOGIA / GENETICA MEDICA Year: 2017 Document type: Article Affiliation country: Spain Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Polymorphism, Single Nucleotide / Cytarabine / Induction Chemotherapy Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Journal: Pharmacogenet Genomics Journal subject: FARMACOLOGIA / GENETICA MEDICA Year: 2017 Document type: Article Affiliation country: Spain Country of publication: United States